Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Georgios Vassilopoulos"'
Autor:
Panagiotis T. Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, Ioannis Kotsianidis, Nora-Athina Viniou, Vassiliki Pappa, Charalampos Pontikoglou, Dimitrios Tsokanas, Georgios Drakos, Alexandra Kourakli, Elena Solomou, Eleftheria Hatzimichael, Anastasia Pouli, Maria Kotsopoulou, Evangelos Asmanis, Maria Dimou, Panayiotis Panayiotidis, Sotirios Papageorgiou, Georgios Vassilopoulos, Achilles Anagnostopoulos, Theodoros Vassilakopoulos, Helen Papadaki, Athanasios Galanopoulos
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Monocytopenia is a common finding in patients with myelodysplastic syndrome (MDS), but although monocytes may exhibit prognostic significance in MDS due to their role in innate immunity, they have not been incorporated in any prognostic scor
Externí odkaz:
https://doaj.org/article/4254279bca284d208c21578c7f5893fb
Autor:
Elissavet Lykoudi, Georgia Fasoi, Evangelia Meimeti, Chariklia Loupa, Arvanitidou Eleni, Georgios Vassilopoulos
Publikováno v:
Ellīniko Periodiko tīs Nosīleutikīs Epistīmīs, Vol 12, Iss 1, Pp 44-52 (2019)
Introduction: Diabetes mellitus is a chronic disease that causes multiple lesions in the human body. The prevalence of the disease is particularly increased at international and national level. It is manifested by high blood glucose levels, while med
Externí odkaz:
https://doaj.org/article/99187057fc4043779952038e34b3c88b
Autor:
Eirini Sevdali, Eleni Katsantoni, Cristian R. Smulski, Maria Moschovi, Maria Palassopoulou, Eleni-Nefeli Kolokotsa, Nikoletta Argentou, Nikolaos Giannakoulas, Maria Adamaki, Georgios Vassilopoulos, Sophia Polychronopoulou, Anastasios E. Germenis, Hermann Eibel, Matthaios Speletas
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
BAFF, APRIL and their receptors regulate the survival, maturation and homeostasis of mature B-cells. Despite the lack of a functional role of BAFF/APRIL system during normal early B-cell development, previous studies indicated a contribution of these
Externí odkaz:
https://doaj.org/article/e2086a125c6c4fdba9c4c6355537ebb0
Autor:
Stefania Kokkali, Ioannis Boukovinas, Epaminondas Samantas, Pavlos Papakotoulas, Ilias Athanasiadis, Charalampos Andreadis, Parisis Makrantonakis, Georgios Samelis, Eleni Timotheadou, Georgios Vassilopoulos, Christos Papadimitriou, Dimitrios Tzanninis, Alexandros Ardavanis, Ioannis Kotsantis, Kiki Karvounis-Marolachakis, Theodora Theodoropoulou, Amanda Psyrri
Publikováno v:
Cancers; Volume 14; Issue 8; Pages: 1879
This non-interventional, multicenter, prospective study aimed to evaluate the real-world activity of trabectedin, and its impact on symptom burden and quality of life in patients with advanced soft tissue sarcoma (aSTS) treated in routine clinical se
Autor:
Eurydiki Michalis, Magdalini Dadakaridou, Argiris Symeonidis, Theodora Assimakopoulou, Vasiliki Pappa, Gerassimos A. Pangalis, Anastasia Pouli, Christos Georgopoulos, Chrysavgi Lalayanni, Panagiotis Repousis, Christos Poziopoulos, Evangelos Terpos, Panagiotis Zikos, Marie-Christine Kyrtsonis, Ioannis Ntanasis-Stathopoulos, Georgios Vassilopoulos, Maria Gavriatopoulou, Kiki Karvounis-Marolachakis, Helen A. Papadaki, Eirini Katodritou, Emmanouil Spanoudakis, Evdoxia Hatjiharissi
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1509, p 1509 (2021)
Journal of Clinical Medicine
Volume 10
Issue 7
Journal of Clinical Medicine
Volume 10
Issue 7
The “POWERFUL” multicenter, retrospective, and prospective study investigated the effectiveness of pomalidomide plus low-dose dexamethasone (POM/LoDex) therapy in relapsed/refractory multiple myeloma in routine care in Greece. Ninety-nine eligibl
Autor:
Georgios Paterakis, Sophia Polychronopoulou, Vassilios Papadakis, Vassilios Vasdekis, Stephanos I. Papadhimitriou, Maria Ampatzidou, Georgios Vassilopoulos
Publikováno v:
Leukemia & Lymphoma. 60:258-261
Treatment response assessment via quantification of minimal residual disease (MRD) has become a corner-stone for risk stratification in pediatric acute lymphoblastic leukemia (ALL). Evaluation of t...
Autor:
Maria Palassopoulou, Christos A. Apostolopoulos, Nikolaos Harhalakis, Ioannis Batsis, A Spyridonidis, Theodoros P. Vassilakopoulos, Dimitrios Grentzelias, Maria K. Angelopoulou, Ioanna Sakellari, Maria Moschogiannis, Dimitrios Margaritis, Panagiota Giannoulia, Ioannis Apostolidis, Panayiotis Panayiotidis, Panagiotis Tsirigotis, Gerassimos A. Pangalis, Elias Poulakidas, Marie-Christine Kyrtsonis, Achilles Anagnostopoulos, Paraskevi Roussou, Eleutheria Hatzimichael, Zoi Bousiou, Georgios Vassilopoulos, Vasiliki Pappa, Konstantinos Anargyrou, Panagiotis Repousis, Konstantinos Gkirkas, Christina Kalpadakis, Maria Dimou, Eurydiki Michalis
Publikováno v:
Hematological Oncology
This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ninety‐five patients with R/R HL
Autor:
Eirini Katodritou, Emmanouil Spanoudakis, Sossana Delimpasi, Helen A. Papadaki, Aikaterini Megalakaki, Maria Kotsopoulou, Dimitrios Gogos, Evangelos Terpos, Georgios Vassilopoulos, Argiris Symeonidis, Marie-Christine Kyrtsonis, Achilles Anagnostopoulos, Panagiotis Zikos, Panagiotis Repousis, Anthi Aktypi, Ioannis Adamopoulos, Anna Kioumi, D.S. Kyriakou, Vassiliki Papa, Evangelos Mpriasoulis
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e130-e131
Autor:
Anastasios E. Germenis, Maria Ioannou, Nikoletta Argentou, Matthaios Speletas, Georgios Vassilopoulos
Publikováno v:
Leukemia. 28:447-449
Rapid detection of MYD88 -L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders
Autor:
Georgios Vassilopoulos, Marina Mantzourani, Dimitris Loukopoulos, Georgios Stamatelos, Vassilios Skoumas, Athanassios Aessopos
Publikováno v:
Chest. 107:50-53
We analyzed seven patients with beta-thalassemia intermedia presenting with congestive heart failure secondary to pulmonary hypertension. This condition has been recognized only recently as part of the clinical spectrum of beta-thalassemia. Our group